7713 logo

WeLeader Biomedical Co., Ltd. Stock Price

TPEX:7713 Community·NT$3.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7713 Share Price Performance

NT$67.70
12.70 (23.09%)
NT$67.70
12.70 (23.09%)
Price NT$67.70

7713 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet.

2 Risks
2 Rewards

WeLeader Biomedical Co., Ltd. Key Details

NT$1.1b

Revenue

NT$738.3m

Cost of Revenue

NT$371.0m

Gross Profit

NT$162.4m

Other Expenses

NT$208.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
4.59
33.44%
18.80%
38.8%
View Full Analysis

About 7713

Founded
1992
Employees
n/a
CEO
Chen Hung-Jen
WebsiteView website
www.weleader.com.tw

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT central laboratory products, and CCM fully automated track processing products. It serves research institutions, schools, hospitals, laboratories, and hospitals. The company was founded in 1992 and is headquartered in Kaohsiung, Taiwan.

Recent 7713 News & Updates

Recent updates

No updates